SF3B1 and B-cell chronic lymphocytic leukemia: Moreover, increased NOTCH1 signaling positively correlated with the expression of altered DVL2 and reduced CD20 expression in SF3B1-mutated CLL cases, suggesting that SF3B1 mutations represent another factor associated with the reduction of CD20 expression through mutation-independent activation of the NOTCH1 pathway.